113 related articles for article (PubMed ID: 38547657)
1. Identification of CREB5 as a prognostic and immunotherapeutic biomarker in glioma through multi-omics pan-cancer analysis.
Wu Z; Wang X; Wu H; Du S; Wang Z; Xie S; Zhang R; Chen G; Chen H
Comput Biol Med; 2024 May; 173():108307. PubMed ID: 38547657
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer.
Chen P; Xu J; Cui Z; Wu S; Xie T; Zhang X
Front Immunol; 2023; 14():1071675. PubMed ID: 36761737
[TBL] [Abstract][Full Text] [Related]
3. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
Front Immunol; 2022; 13():849592. PubMed ID: 35444654
[TBL] [Abstract][Full Text] [Related]
4. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
[TBL] [Abstract][Full Text] [Related]
5. A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.
Wu X; Chen H; You C; Peng Z
Hereditas; 2023 May; 160(1):21. PubMed ID: 37170390
[TBL] [Abstract][Full Text] [Related]
6. Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification.
Peng Z; Wang J; Tong S; Wu Y; Yi D; Xiang W
Front Immunol; 2023; 14():1128151. PubMed ID: 37006287
[TBL] [Abstract][Full Text] [Related]
7. Multi-omics analysis of the oncogenic value of copper Metabolism-Related protein COMMD2 in human cancers.
Tai P; Wang Z; Chen X; Chen A; Gong L; Cheng Y; Cao K
Cancer Med; 2023 May; 12(10):11941-11959. PubMed ID: 36205192
[TBL] [Abstract][Full Text] [Related]
8. microRNA-206 prevents hepatocellular carcinoma growth and metastasis via down-regulating CREB5 and inhibiting the PI3K/AKT signaling pathway.
Chi Y; Gong Z; Xin H; Wang Z; Liu Z
Cell Cycle; 2022 Dec; 21(24):2651-2663. PubMed ID: 36003063
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG5 affects cell proliferation, metastasis and migration of colorectal cancer through regulating miR-132-3p/CREB5.
Zhang M; Li Y; Wang H; Yu W; Lin S; Guo J
Cancer Biol Ther; 2019; 20(4):524-536. PubMed ID: 30395767
[TBL] [Abstract][Full Text] [Related]
10. Liquid-liquid phase separation-related gene in gliomas: FABP5 is a potential prognostic marker.
Tang Q; Mao X; Chen Z; Ma C; Tu Y; Zhu Q; Lu J; Wang Z; Zhang Q; Wu W
J Gene Med; 2023 Oct; 25(10):e3517. PubMed ID: 37114595
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
12. Pan-Cancer Analysis Identifies CHD5 as a Potential Biomarker for Glioma.
Xu L; Shao F; Luo T; Li Q; Tan D; Tan Y
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955624
[TBL] [Abstract][Full Text] [Related]
13. TGIF2 is a potential biomarker for diagnosis and prognosis of glioma.
Zhang W; Zhang L; Dong H; Peng H
Front Immunol; 2024; 15():1356833. PubMed ID: 38629068
[TBL] [Abstract][Full Text] [Related]
14. Integrative multi-omics analyses unravel the immunological implication and prognostic significance of CXCL12 in breast cancer.
Gao ZJ; Fang Z; Yuan JP; Sun SR; Li B
Front Immunol; 2023; 14():1188351. PubMed ID: 37564657
[TBL] [Abstract][Full Text] [Related]
15. Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma.
Xiong Y; Qi Y; Pan Z; Wang S; Li B; Feng B; Xue H; Zhao R; Li G
Cancer Cell Int; 2022 Sep; 22(1):294. PubMed ID: 36163046
[TBL] [Abstract][Full Text] [Related]
16. Multiomics blueprint of PANoptosis in deciphering immune characteristics and prognosis stratification of glioma patients.
Chen M; Huang M; Chen X; Lin X; Chen X
J Gene Med; 2024 Jan; 26(1):e3621. PubMed ID: 37997255
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.
Zhu J; Chen Q; Zeng L; Gao H; Wu T; He Y; Xu J; Pang J; Peng J; Deng Y; Han Y; Yi W
Front Immunol; 2023; 14():1236806. PubMed ID: 37901236
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-204/CREB5 axis regulates vasculogenic mimicry in breast cancer cells.
Contreras-Sanzón E; Palma-Flores C; Flores-Pérez A; M Salinas-Vera Y; B Silva-Cázares M; A Marchat L; G Avila-Bonilla R; N Hernández de la Cruz O; E Álvarez-Sánchez M; Pérez-Plasencia C; D Campos-Parra A; López-Camarillo C
Cancer Biomark; 2022; 35(1):47-56. PubMed ID: 35662106
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Prognostic Analysis of Immune Implication Value and Oxidative Stress Significance of NECAP2 in Low-Grade Glioma.
Lu Z; Chen Y; Chen S; Zhu X; Wang C; Wang Z; Yao Q
Oxid Med Cell Longev; 2022; 2022():1494520. PubMed ID: 36531205
[TBL] [Abstract][Full Text] [Related]
20. IL4I1 in M2-like macrophage promotes glioma progression and is a promising target for immunotherapy.
Ye F; Wang L; Li Y; Dong C; Zhou L; Xu J
Front Immunol; 2023; 14():1338244. PubMed ID: 38250074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
